Suan, Leonardo B.
HRN: 01-43-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
LEVOFLOXACIN 500MG (TAB)
09/02/2023
09/09/2023
ORAL
500mg
OD
COPD; CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes